- About Us
- Nano-Social Network
- Nano Consulting
- My Account
January 3rd, 2008
Investor Spotlight: Golden Pine Ventures
Golden Pine Ventures, founded in the summer of 2004, has not disclosed the size of its fund, but Meldrum says it has enough to do between six and eight investments in the early-stage biotechnology and biomedical companies it favors.
Meldrum says the firm's typical investment depends on the opportunity, but has invested $100,000 in a couple. "We're looking at opportunities where we want to get to proof of concept," he says.
As an example, he cites the firm's only non-Southeastern investment in Kylin, which employs a revolutionary RNA nanoparticle technology platform called "pRNA" to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases.
|Related News Press|
News and information
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers